ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    TIME-2b
Previous Study | Return to List | Next Study

The TIME-2b Study: A Study of AKB-9778, a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR) (TIME-2b)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03197870
Recruitment Status : Active, not recruiting
First Posted : June 23, 2017
Last Update Posted : February 12, 2018
Sponsor:
Information provided by (Responsible Party):
Aerpio Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : May 2019
  Estimated Study Completion Date : June 2019